Innovation from ASTech
hemaPEN is a product concept developed through ASTech, the ARC Training Centre for Portable Analytical Separation Technologies – and has huge potential to benefit to a range of diseases including diabetes, therapeutic drug monitoring and medical research.
Since the initial concept, there has been further development by Trajan Scientific and Medical.
hemaPEN is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only. It is available for research purposes in other areas.
ARTG number: 280007, US FDA number: D410490